At Smilow Cancer Hospital, brain tumor specialists will have access to the most advanced surgical tools and robot-assisted machines, including intra-operative magnetic resonance imaging (MRI) and functional MRI for language and critical motor and language skills mapping.
The Brain Tumor Program offers a wide spectrum of tools to diagnose and treat brain cancer, making it possible to make precise diagnoses and develop more effective interventions for tumors of the brain. Patients benefit from specialized resources such as a dedicated neurological intensive care unit and the latest imaging technologies.
A full range of traditional and innovative treatments is available, including surgery, radiation oncology, stereotactic radiosurgery, chemotherapy and novel experimental therapies.
The Brain Tumor Program has gained regional and national recognition for continually pushing science and technology toward a cure. Clinical trials for newly diagnosed and relapsed glioblastoma multiforme (GBM) — the most common and most aggressive type of primary brain tumor — are based on tumor-directed vaccines and antiangiogenic drugs that stop new vessels from forming around a tumor and break up the existing network of abnormal capillaries that feeds the cancerous mass. Physicians in the Brain Tumor Program maintain a close working relationship with physicians practicing in the community. They welcome referrals and supply physicians with regular reports on diagnostic findings and treatment recommendations. Patients can be referred for the development of a treatment plan in conjunction with their primary physician, for a second opinion, or for ongoing management by the Brain Tumor Program physicians.